ALMS1 and metabolic syndrome: At 24 weeks, global Alms1 KO mice were indeed strikingly hyperlipidemic (Table 1), albeit with a different pattern to human dyslipidemia, which features elevated serum triglyceride and suppressed HDL cholesterol.